查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
動物感染疾病診斷市場 - 全球和區域分析：按技術、產品、動物類型、感染類型、最終用戶和區域 - 分析和預測（2025-2035年）
市場調查報告書
商品編碼
1814815

動物感染疾病診斷市場 - 全球和區域分析：按技術、產品、動物類型、感染類型、最終用戶和區域 - 分析和預測（2025-2035年）

Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 120 Pages | 商品交期: 1-5個工作天內

價格

全球動物感染疾病診斷市場 - 分析與預測（2025-2035）

獸醫感染疾病診斷是指透過各種實驗室測試和診斷技術來識別和檢測動物感染疾病。

這些疾病不僅影響犬、貓、馬等伴侶動物，也影響牛、家禽和豬等牲畜。早期準確檢測對於控制疫情、保障動物福利、防止通用感染疾病從動物傳播給人類非常重要。

診斷方法包括分子技術，例如PCR和次世代定序，可在基因層面識別病原體；免疫診斷測試，例如ELISA，可檢測抗體和抗原；以及微生物培養，可分離細菌和病毒。快速診斷測試也常用於現場快速識別疾病。總體而言，獸醫感染疾病診斷在疾病預防、動物健康管理和公共衛生保護中發揮著非常重要的作用。因此，是獸醫、農民和寵物飼主就治療和護理做出明智決策的重要工具。

獸醫感染疾病診斷的主要優勢之一是能夠早期發現並準確識別動物感染疾病。早期識別非常重要，因為它可以及時治療，降低疾病嚴重程度，並防止其傳播給其他動物，甚至在通用感染疾病，防止其傳播給人類。準確的診斷使獸醫能夠識別導致感染疾病的特定病原體，進行針對性治療，而不是使用廣譜抗生素或無效藥物。這不僅可以提高治療效果，還可以透過避免不必要的抗生素使用來降低抗生素抗藥性的風險。

此外，及時檢測有助於快速識別疫情，最大限度地減少畜牧業的經濟損失，並確保寵物和其他動物的健康和福利，控制和預防疾病。總而言之，獸醫感染疾病診斷可以改善動物健康，增強動物福利，並提高公共衛生安全。

動物感染疾病診斷市場的主要驅動力之一是通用感染疾病的盛行率不斷上升，感染疾病疾病由動物傳播通用人類，對公共健康構成重大風險，促使獸醫加強監測和診斷工作。

對這些風險的認知不斷提高，推動了對快速且準確的診斷工具的需求，以檢測伴侶動物和牲畜的感染。這一趨勢在北美等地區尤其明顯，通用感染疾病發生率的上升推動了分子診斷、就地檢驗和次世代定序等先進診斷技術的採用。

儘管獸醫感染疾病診斷市場成長，但仍存在一些挑戰。其中一個主要挑戰是診斷測試和先進技術的高成本。雖然分子診斷、PCR檢測和次世代定序能夠提供高度準確的結果，但它們需要在設備、試劑和培訓方面投入大量資金。這種高成本對許多獸醫診所，尤其是資源匱乏地區或小型診所來說，可能是一個障礙。此外，這些技術的複雜性需要熟練的專業人員，這進一步增加了實施成本。

另一個挑戰是不同地區缺乏標準化的法規和統一的診斷方法。不一致的監管標準可能導致診斷工具的品質和可用性存在差異，可能影響其廣泛應用。此外，需要加強全球協調，以確保診斷工具符合國際標準，尤其是在通用感染疾病易發地區。

此外，由於抵制變革以及缺乏對先進診斷能力的了解等因素，一些市場對新技術的採用緩慢，這也導致了市場成長緩慢。克服這些挑戰對於確保公平獲得優質診斷服務以及改善全球動物健康管理非常重要。

全球動物感染疾病診斷市場競爭激烈，主要由 IDEXX Laboratories, Inc.、Zoetis、Thermo Fisher Scientific Inc.、Virbac、bioMerieux SA、Heska Corporation、Neogen Corporation、Randox Laboratories Ltd.、Agrolabo SpA、Indical Bioscience GmbH（QCheiagen NVie）等大型公司主導。

這些公司致力於開發先進的診斷解決方案，以滿足日益成長的對動物感染疾病準確及時檢測的需求。其多樣化的產品系列包括分子診斷、免疫診斷和適用於各種獸醫應用的快速檢測套組。動物健康管理需求的不斷成長、人們對通用感染疾病的認知不斷提高以及診斷技術的進步，刺激市場競爭和創新，進一步提高獸醫診斷的可用性和有效性。

動物感染疾病診斷市場細分

細分1：依技術

  • 免疫診斷劑
    • 橫向流動化驗
    • ERISA測試
    • 其他
  • 分子診斷
  • 聚合酵素鏈鎖反應（PCR）檢測
    • 微陣列
    • 其他
  • 其他技術

細分 2：依產品

  • 耗材、試劑和套件
  • 設備/器具

細分3：依動物類型

  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 其他
  • 食用動物
    • 牛
    • 豬
    • 家禽
    • 其他

細分 4：依感染類型

  • 伴侶動物
    • 病毒感染
    • 細菌感染
    • 寄生蟲感染
    • 其他
  • 食用動物
    • 病毒感染疾病
    • 細菌感染疾病
    • 寄生蟲感染疾病
    • 其他

細分 5：依最終用戶

  • 獸醫參考實驗室
  • 獸醫醫院和診所
  • 即時診斷/院內檢測
  • 獸醫研究機構和大學

細分6：依地區

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

全球動物感染疾病診斷市場最重要的新興趨勢之一是將人工智慧（AI）和機器學習（ML）技術融入診斷平台。這些進步提高診斷的準確性、速度和效率，尤其是在照護現場。

人工智慧和機器學習演算法能夠分析圖像和基因組資訊等複雜資料集，更有效地識別病原體並預測疾病爆發。例如，人工智慧診斷工具可以幫助獸醫及早發現伴侶動物和牲畜的感染疾病，及時介入並改善動物健康。

人工智慧和機器學習的採用也將促進可在現場使用的快速診斷測試的開發，減少對集中實驗室的依賴並實現更快的決策，這一趨勢對於獸醫診斷基礎設施有限的地區尤其有利。

總體而言，人工智慧和機器學習融入獸醫診斷改變動物保健的格局，使疾病檢測更加便捷和高效，並支持更佳管理動物感染疾病。

目錄

執行摘要

第1章 全球動物感染疾病診斷市場：產業展望

  • 介紹
  • 市場趨勢
  • 法律規範
  • 專利分析
  • 案例研究
  • 產品基準
  • 市場動態

第2章 全球動物感染疾病診斷市場（依技術），2024-2035

  • 免疫診斷
  • 分子診斷
  • 聚合酵素鏈鎖反應（PCR）檢測
  • 其他

第3章 全球動物感染疾病診斷市場（依產品），2024-2035

  • 耗材、試劑和套件
  • 設備和儀器

第4章 2024-2035年全球動物感染疾病診斷市場（依動物類型）

  • 伴侶動物
  • 食用動物

第5章 全球動物感染疾病診斷市場（依感染疾病類型），2024-2035

  • 伴侶動物
  • 食用動物

第6章 2024-2035年全球動物感染疾病診斷市場（依最終使用者）

  • 獸醫參考實驗室
  • 獸醫醫院和診所
  • 照護現場/內部偵測
  • 獸醫研究機構和大學

第7章 2023-2035年全球動物感染疾病診斷市場（依地區）

  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第8章 全球動物感染疾病診斷市場：競爭格局與公司簡介

  • 關鍵策略和發展
  • 公司簡介
    • IDEXX Laboratories, Inc.
    • Zoetis
    • Thermo Fisher Scientific Inc.
    • Virbac
    • bioMerieux SA
    • Heska Corporation
    • Neogen Corporation
    • Randox Laboratories Ltd.
    • Agrolabo SpA
    • Indical Bioscience GmbH（Qiagen NV）
    • BioChek（bioMerieux）
    • Antech Diagnostics, Inc.
    • IDVet
    • Bio-Rad Laboratories, Inc
    • Shenzhen Bioeasy Biotechnology Co., Ltd.

第9章 調查方法

Product Code: BHM3264SA

Global Veterinary Infectious Disease Diagnostics Market, Analysis and Forecast: 2025-2035

Veterinary infectious disease diagnostics refers to the identification and detection of infectious diseases in animals through various laboratory tests and diagnostic techniques. These diseases can affect both companion animals like dogs, cats, and horses, as well as livestock such as cattle, poultry, and swine. Early and accurate detection is crucial for controlling outbreaks, ensuring animal welfare, and preventing the spread of zoonotic diseases those that can be transmitted from animals to humans.

Diagnostic methods include molecular techniques like PCR and Next-Generation Sequencing for identifying pathogens at the genetic level, immunodiagnostic tests such as ELISA to detect antibodies or antigens, and microbiological cultures to isolate bacteria or viruses. Rapid diagnostic tests are also commonly used in field settings for quick disease identification. Overall, veterinary infectious disease diagnostics plays a vital role in disease prevention, animal health management, and safeguarding public health. As such, it is an essential tool for veterinarians, farmers, and pet owners to make informed decisions regarding treatment and care.

One of the primary advantages of veterinary infectious disease diagnostics is its ability to enable early detection and precise identification of infectious diseases in animals. Early identification is crucial because it allows for prompt treatment, reducing the severity of the disease and preventing its spread to other animals or even to humans in the case of zoonotic diseases. Accurate diagnostics help veterinarians determine the specific pathogen responsible for an infection, which enables targeted treatments rather than broad-spectrum antibiotics or ineffective medications. This not only improves the effectiveness of treatments but also reduces the risk of antimicrobial resistance by avoiding unnecessary use of antibiotics.

Additionally, timely detection helps in disease management and prevention by identifying outbreaks quickly, thereby minimizing economic losses in livestock industries and ensuring the health and welfare of pets and other animals. Overall, veterinary infectious disease diagnostics supports better animal health outcomes, improves animal welfare, and enhances public health safety.

One of the key drivers of the veterinary infectious disease diagnostics market is the rising prevalence of zoonotic diseases. Zoonotic diseases those transmitted from animals to humans pose significant public health risks and have prompted increased surveillance and diagnostic efforts in veterinary medicine.

The growing awareness of these risks has led to heightened demand for rapid and accurate diagnostic tools to detect infections in both companion animals and livestock. This trend is particularly evident in regions like North America, where the increasing incidence of zoonotic diseases is driving the adoption of advanced diagnostic technologies such as molecular diagnostics, point-of-care testing, and next-generation sequencing.

Despite the growth of the veterinary infectious disease diagnostics market, several challenges persist. One of the primary challenges is the high cost of diagnostic tests and advanced technologies. While molecular diagnostics, PCR assays, and next-generation sequencing provide highly accurate results, they require significant investment in equipment, reagents, and training. This high cost can be a barrier for many veterinary clinics, especially in low-resource settings or for smaller practices. Additionally, the complexity of these technologies demands skilled professionals, further increasing the cost of implementation.

Another challenge is the lack of standardized regulations and uniformity in diagnostic practices across different regions. Inconsistent regulatory standards can lead to variations in the quality and availability of diagnostic tools, affecting their widespread adoption. There is also a need for more global coordination to ensure that diagnostic tools meet international standards, particularly in areas prone to zoonotic outbreaks.

Furthermore, the slow adoption of new technologies in certain markets due to factors such as resistance to change and lack of awareness about advanced diagnostic capabilities contributes to slower market growth in some regions. Overcoming these challenges is crucial for ensuring equitable access to high-quality diagnostics and improving animal health management worldwide.

The global Veterinary Infectious Disease Diagnostics market is highly competitive, with major players such as IDEXX Laboratories, Inc., Zoetis, Thermo Fisher Scientific Inc., Virbac, bioMerieux S.A., Heska Corporation, Neogen Corporation, Randox Laboratories Ltd., Agrolabo S.p.A., Indical Bioscience GmbH (Qiagen N.V.), and BioChek (bioMerieux) leading the way.

These companies are focused on developing advanced diagnostic solutions to address the growing need for accurate and timely detection of infectious diseases in animals. Their diverse product portfolios include molecular diagnostics, immunodiagnostics, and rapid testing kits, catering to a wide range of veterinary applications. The increasing demand for animal health management, rising awareness of zoonotic diseases, and advancements in diagnostic technology are fueling competition and innovation in the market, further enhancing the availability and effectiveness of veterinary diagnostics.

Veterinary Infectious Disease Diagnostics Market Segmentation:

Segmentation 1: by Technology

  • Immunodiagnostics
    • Lateral Flow Assays
    • Elisa Tests
    • Other Immunodiagnostic Products
  • Molecular Diagnostics
  • Polymerase Chain Reaction (PCR) Tests
    • Microarrays
    • Other Molecular Diagnostic Products
  • Other Technologies

Segmentation 2: by Product

  • Consumables, Reagents & Kits
  • Equipment & Instruments

Segmentation 3: by Animal Type

  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Food-Producing Animals
    • Cattle
    • Swine
    • Poultry
    • Other food-producing animals

Segmentation 4: by Infection Type

  • Companion Animals
    • Viral infections
    • Bacterial infections
    • Parasitic infections
    • Other infections
  • Food-Producing Animals
    • Viral infections
    • Bacterial infections
    • Parasitic infections
    • Other infections

Segmentation 5: by End User

  • Veterinary Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Point-Of-Care/ In-House Testing
  • Veterinary Research Institutes & Universities

Segmentation 6: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

One of the most significant emerging trends in the global veterinary infectious disease diagnostics market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into diagnostic platforms. These advancements are enhancing the accuracy, speed, and efficiency of diagnostics, particularly in point-of-care settings.

AI and ML algorithms enable the analysis of complex data sets, such as imaging and genomic information, to identify pathogens and predict disease outbreaks more effectively. For instance, AI-powered diagnostic tools can assist veterinarians in detecting infections in companion animals and livestock at earlier stages, leading to timely interventions and improved animal health outcomes.

The adoption of AI and ML is also facilitating the development of rapid diagnostic tests that can be used in field settings, reducing the reliance on centralized laboratories and enabling quicker decision-making. This trend is particularly beneficial in regions with limited access to veterinary diagnostic infrastructure.

Overall, the incorporation of AI and ML into veterinary diagnostics is transforming the landscape of animal healthcare, making disease detection more accessible and efficient, and supporting better management of infectious diseases in animals.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Veterinary Infectious Disease Diagnostics Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Veterinary Infectious Disease Diagnostics Market (by Technology), ($Billion), 2024-2035

  • 2.1 Immunodiagnostics
    • 2.1.1 Lateral Flow Assays
    • 2.1.2 Elisa Tests
    • 2.1.3 Other Immunodiagnostic Products
  • 2.2 Molecular Diagnostics
  • 2.3 Polymerase Chain Reaction (PCR) Tests
    • 2.3.1 Microarrays
    • 2.3.2 Other Molecular Diagnostic Products
  • 2.4 Other Technologies

3. Global Veterinary Infectious Disease Diagnostics Market (by Product), ($Billion), 2024-2035

  • 3.1 Consumables, Reagents & Kits
  • 3.2 Equipment & Instruments

4. Global Veterinary Infectious Disease Diagnostics Market (by Animal Type), ($Billion), 2024-2035

  • 4.1 Companion Animals
    • 4.1.1 Dogs
    • 4.1.2 Cats
    • 4.1.3 Horses
    • 4.1.4 Other Companion Animals
  • 4.2 Food-Producing Animals
    • 4.2.1 Cattle
    • 4.2.2 Swine
    • 4.2.3 Poultry
    • 4.2.4 Other food-producing animals

5. Global Veterinary Infectious Disease Diagnostics Market (by Infection Type), ($Billion), 2024-2035

  • 5.1 Companion Animals
    • 5.1.1 Viral infections
    • 5.1.2 Bacterial infections
    • 5.1.3 Parasitic infections
    • 5.1.4 Other infections
  • 5.2 Food-Producing Animals
    • 5.2.1 Viral infections
    • 5.2.2 Bacterial infections
    • 5.2.3 Parasitic infections
    • 5.2.4 Other infections

6. Global Veterinary Infectious Disease Diagnostics Market (by End User), ($Billion), 2024-2035

  • 6.1 Veterinary Reference Laboratories
  • 6.2 Veterinary Hospitals & Clinics
  • 6.3 Point-Of-Care/ In-House Testing
  • 6.4 Veterinary Research Institutes & Universities

7. Global Veterinary Infectious Disease Diagnostics Market (by Region), ($Billion), 2023-2035

  • 7.1 North America
    • 7.1.1 Key Findings
    • 7.1.2 Market Dynamics
    • 7.1.3 Market Sizing and Forecast
      • 7.1.3.1 North America Veterinary Infectious Disease Diagnostics Market, by Country
        • 7.1.3.1.1 U.S.
        • 7.1.3.1.2 Canada
  • 7.2 Europe
    • 7.2.1 Key Findings
    • 7.2.2 Market Dynamics
    • 7.2.3 Market Sizing and Forecast
      • 7.2.3.1 Europe Veterinary Infectious Disease Diagnostics Market, by Country
        • 7.2.3.1.1 Germany
        • 7.2.3.1.2 U.K.
        • 7.2.3.1.3 France
        • 7.2.3.1.4 Italy
        • 7.2.3.1.5 Spain
        • 7.2.3.1.6 Rest of the Europe
  • 7.3 Asia Pacific
    • 7.3.1 Key Findings
    • 7.3.2 Market Dynamics
    • 7.3.3 Market Sizing and Forecast
      • 7.3.3.1 Asia Pacific Veterinary Infectious Disease Diagnostics Market, by Country
        • 7.3.3.1.1 China
        • 7.3.3.1.2 Japan
        • 7.3.3.1.3 India
        • 7.3.3.1.4 Australia
        • 7.3.3.1.5 Rest of Asia Pacific
  • 7.4 Rest of the World
    • 7.4.1 Key Findings
    • 7.4.2 Market Dynamics
    • 7.4.3 Market Sizing and Forecast

8. Global Veterinary Infectious Disease Diagnostics Market: Competitive Landscape and Company Profiles

  • 8.1 Key Strategies and Development
    • 8.1.1 Mergers and Acquisitions
    • 8.1.2 Synergistic Activities
    • 8.1.3 Business Expansions and Funding
    • 8.1.4 Product Launches and Approvals
    • 8.1.5 Other Activities
  • 8.2 Company Profiles
    • 8.2.1 IDEXX Laboratories, Inc.
      • 8.2.1.1 Overview
      • 8.2.1.2 Top Products / Product Portfolio
      • 8.2.1.3 Top Competitors
      • 8.2.1.4 Target Customers/End-Users
      • 8.2.1.5 Key Personnel
      • 8.2.1.6 Analyst View
    • 8.2.2 Zoetis
      • 8.2.2.1 Overview
      • 8.2.2.2 Top Products / Product Portfolio
      • 8.2.2.3 Top Competitors
      • 8.2.2.4 Target Customers/End-Users
      • 8.2.2.5 Key Personnel
      • 8.2.2.6 Analyst View
    • 8.2.3 Thermo Fisher Scientific Inc.
      • 8.2.3.1 Overview
      • 8.2.3.2 Top Products / Product Portfolio
      • 8.2.3.3 Top Competitors
      • 8.2.3.4 Target Customers/End-Users
      • 8.2.3.5 Key Personnel
      • 8.2.3.6 Analyst View
    • 8.2.4 Virbac
      • 8.2.4.1 Overview
      • 8.2.4.2 Top Products / Product Portfolio
      • 8.2.4.3 Top Competitors
      • 8.2.4.4 Target Customers/End-Users
      • 8.2.4.5 Key Personnel
      • 8.2.4.6 Analyst View
    • 8.2.5 bioMerieux S.A.
      • 8.2.5.1 Overview
      • 8.2.5.2 Top Products / Product Portfolio
      • 8.2.5.3 Top Competitors
      • 8.2.5.4 Target Customers/End-Users
      • 8.2.5.5 Key Personnel
      • 8.2.5.6 Analyst View
    • 8.2.6 Heska Corporation
      • 8.2.6.1 Overview
      • 8.2.6.2 Top Products / Product Portfolio
      • 8.2.6.3 Top Competitors
      • 8.2.6.4 Target Customers/End-Users
      • 8.2.6.5 Key Personnel
      • 8.2.6.6 Analyst View
    • 8.2.7 Neogen Corporation
      • 8.2.7.1 Overview
      • 8.2.7.2 Top Products / Product Portfolio
      • 8.2.7.3 Top Competitors
      • 8.2.7.4 Target Customers/End-Users
      • 8.2.7.5 Key Personnel
      • 8.2.7.6 Analyst View
    • 8.2.8 Randox Laboratories Ltd.
      • 8.2.8.1 Overview
      • 8.2.8.2 Top Products / Product Portfolio
      • 8.2.8.3 Top Competitors
      • 8.2.8.4 Target Customers/End-Users
      • 8.2.8.5 Key Personnel
      • 8.2.8.6 Analyst View
    • 8.2.9 Agrolabo S.p.A.
      • 8.2.9.1 Overview
      • 8.2.9.2 Top Products / Product Portfolio
      • 8.2.9.3 Top Competitors
      • 8.2.9.4 Target Customers/End-Users
      • 8.2.9.5 Key Personnel
      • 8.2.9.6 Analyst View
    • 8.2.10 Indical Bioscience GmbH (Qiagen N.V.)
      • 8.2.10.1 Overview
      • 8.2.10.2 Top Products / Product Portfolio
      • 8.2.10.3 Top Competitors
      • 8.2.10.4 Target Customers/End-Users
      • 8.2.10.5 Key Personnel
      • 8.2.10.6 Analyst View
    • 8.2.11 BioChek (bioMerieux)
      • 8.2.11.1 Overview
      • 8.2.11.2 Top Products / Product Portfolio
      • 8.2.11.3 Top Competitors
      • 8.2.11.4 Target Customers/End-Users
      • 8.2.11.5 Key Personnel
      • 8.2.11.6 Analyst View
    • 8.2.12 Antech Diagnostics, Inc.
      • 8.2.12.1 Overview
      • 8.2.12.2 Top Products / Product Portfolio
      • 8.2.12.3 Top Competitors
      • 8.2.12.4 Target Customers/End-Users
      • 8.2.12.5 Key Personnel
      • 8.2.12.6 Analyst View
    • 8.2.13 IDVet
      • 8.2.13.1 Overview
      • 8.2.13.2 Top Products / Product Portfolio
      • 8.2.13.3 Top Competitors
      • 8.2.13.4 Target Customers/End-Users
      • 8.2.13.5 Key Personnel
      • 8.2.13.6 Analyst View
    • 8.2.14 Bio-Rad Laboratories, Inc
      • 8.2.14.1 Overview
      • 8.2.14.2 Top Products / Product Portfolio
      • 8.2.14.3 Top Competitors
      • 8.2.14.4 Target Customers/End-Users
      • 8.2.14.5 Key Personnel
      • 8.2.14.6 Analyst View
    • 8.2.15 Shenzhen Bioeasy Biotechnology Co., Ltd.
      • 8.2.15.1 Overview
      • 8.2.15.2 Top Products / Product Portfolio
      • 8.2.15.3 Top Competitors
      • 8.2.15.4 Target Customers/End-Users
      • 8.2.15.5 Key Personnel
      • 8.2.15.6 Analyst View

9. Research Methodology

List of Figures

  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Technology), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Product), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Animal Type), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Infection Type), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market Key Trends, Analysis

List of Tables

  • Table: Global Veterinary Infectious Disease Diagnostics Market Dynamics, Impact Analysis
  • Table: Global Veterinary Infectious Disease Diagnostics Market (by Region), $Billion, 2024-2035